Search

Your search keyword '"Bowman, Natalie M"' showing total 226 results
Start Over Author "Bowman, Natalie M"
226 results on '"Bowman, Natalie M"'

2. Estimating the generation time for influenza transmission using household data in the United States

Author

Chan, Louis Yat Hin, Morris, Sinead E., Stockwell, Melissa S., Bowman, Natalie M., Asturias, Edwin, Rao, Suchitra, Lutrick, Karen, Ellingson, Katherine D., Nguyen, Huong Q., Maldonado, Yvonne, McLaren, Son H., Sano, Ellen, Biddle, Jessica E., Smith-Jeffcoat, Sarah E., Biggerstaff, Matthew, Rolfes, Melissa A., Talbot, H. Keipp, Grijalva, Carlos G., Borchering, Rebecca K., and Mellis, Alexandra M.

Published
2025
Full Text
View/download PDF

3. Neurodevelopment in preschool children exposed and unexposed to Zika virus in utero in Nicaragua: a prospective cohort study

Author

Max, Ryan, Toval-Ruiz, Christian, Becker-Dreps, Sylvia, Gajewski, Anna M, Martinez, Evelin, Cross, Kaitlyn, Blette, Bryan, Ortega, Oscar, Collado, Damaris, Zepeda, Omar, Familiar, Itziar, Boivin, Michael J, Chavarria, Meylin, Meléndez, María José, Mercado, Juan Carlos, de Silva, Aravinda, Collins, Matthew H, Westreich, Daniel, Bos, Sandra, Harris, Eva, Balmaseda, Angel, Gower, Emily W, Bowman, Natalie M, Stringer, Elizabeth, and Bucardo, Filemón

Published
2024
Full Text
View/download PDF

4. Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies

Author

Figueiredo, Jane C, Hirsch, Fred R, Kushi, Lawrence H, Nembhard, Wendy N, Crawford, James M, Mantis, Nicholas, Finster, Laurel, Merin, Noah M, Merchant, Akil, Reckamp, Karen L, Melmed, Gil Y, Braun, Jonathan, McGovern, Dermot, Parekh, Samir, Corley, Douglas A, Zohoori, Namvar, Amick, Benjamin C, Du, Ruofei, Gregersen, Peter K, Diamond, Betty, Taioli, Emanuela, Sariol, Carlos, Espino, Ana, Weiskopf, Daniela, Gifoni, Alba, Brien, James, Hanege, William, Lipsitch, Marc, Zidar, David A, McAlearney, Ann Scheck, Wajnberg, Ania, LaBaer, Joshua, Lewis, E Yvonne, Binder, Raquel A, Moormann, Ann M, Forconi, Catherine, Forrester, Sarah, Batista, Jennifer, Schieffelin, John, Kim, Dongjoo, Biancon, Giulia, VanOudenhove, Jennifer, Halene, Stephanie, Fan, Rong, Barouch, Dan H, Alter, Galit, Pinninti, Swetha, Boppana, Suresh B, Pati, Sunil K, Latting, Misty, Karaba, Andrew H, Roback, John, Sekaly, Rafick, Neish, Andrew, Brincks, Ahnalee M, Granger, Douglas A, Karger, Amy B, Thyagarajan, Bharat, Thomas, Stefani N, Klein, Sabra L, Cox, Andrea L, Lucas, Todd, Furr-Holden, Debra, Key, Kent, Jones, Nicole, Wrammerr, Jens, Suthar, Mehul, Wong, Serre Yu, Bowman, Natalie M, Simon, Viviana, Richardson, Lynne D, McBride, Russell, Krammer, Florian, Rana, Meenakshi, Kennedy, Joshua, Boehme, Karl, Forrest, Craig, Granger, Steve W, Heaney, Christopher D, Lapinski, Maria Knight, Wallet, Shannon, Baric, Ralph S, Schifanella, Luca, Lopez, Marcos, Fernández, Soledad, Kenah, Eben, Panchal, Ashish R, Britt, William J, Sanz, Iñaki, Dhodapkar, Madhav, Ahmed, Rafi, Bartelt, Luther A, Markmann, Alena J, Lin, Jessica T, Hagan, Robert S, Wolfgang, Matthew C, and Skarbinski, Jacek

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Pneumonia & Influenza, Vaccine Related, Emerging Infectious Diseases, Biodefense, Lung, Digestive Diseases, Infectious Diseases, Clinical Research, Pneumonia, Cancer, Pediatric, Prevention, Aetiology, 2.4 Surveillance and distribution, Good Health and Well Being, cohort, COVID-19, epidemiology, SARS-CoV-2, serosurveillance, SeroNet, Clinical sciences, Medical microbiology
Abstract

BackgroundGlobal efforts are needed to elucidate the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the underlying cause of coronavirus disease 2019 (COVID-19), including seroprevalence, risk factors, and long-term sequelae, as well as immune responses after vaccination across populations and the social dimensions of prevention and treatment strategies.MethodsIn the United States, the National Cancer Institute in partnership with the National Institute of Allergy and Infectious Diseases, established the SARS-CoV-2 Serological Sciences Network (SeroNet) as the nation's largest coordinated effort to study coronavirus disease 2019. The network comprises multidisciplinary researchers bridging gaps and fostering collaborations among immunologists, epidemiologists, virologists, clinicians and clinical laboratories, social and behavioral scientists, policymakers, data scientists, and community members. In total, 49 institutions form the SeroNet consortium to study individuals with cancer, autoimmune disease, inflammatory bowel diseases, cardiovascular diseases, human immunodeficiency virus, transplant recipients, as well as otherwise healthy pregnant women, children, college students, and high-risk occupational workers (including healthcare workers and first responders).ResultsSeveral studies focus on underrepresented populations, including ethnic minorities and rural communities. To support integrative data analyses across SeroNet studies, efforts are underway to define common data elements for standardized serology measurements, cellular and molecular assays, self-reported data, treatment, and clinical outcomes.ConclusionsIn this paper, we discuss the overarching framework for SeroNet epidemiology studies, critical research questions under investigation, and data accessibility for the worldwide scientific community. Lessons learned will help inform preparedness and responsiveness to future emerging diseases.

Published
2022

5. Chagas disease in the United States: a call for increased investment and collaborative research

Author

Bourque, Daniel, Bowman, Natalie M., Carrion, Malwina, Coyle, Christina, Dauphinais, Madolyn, DeToy, Kelly, Gilman, Robert, Hamer, Davidson H., Herick, Jesica, Hernandez, Salvador, Herrera, Claudia, Marcus, Rachel, Meymandi, Sheba, Nolan, Melissa, Reifler, Katherine, Showler, Adrienne, Granados, Paula Stigler, Takyar, Anshule, Talaat, Kawsar, Waters, Shilah, Wheelock, Alyse, Agudelo Higuita, Nelson Iván, Beatty, Norman L., Forsyth, Colin, Henao-Martínez, Andrés F., and Manne-Goehler, Jennifer

Published
2024
Full Text
View/download PDF

6. SARS-CoV-2 infection of the oral cavity and saliva

Author

Huang, Ni, Pérez, Paola, Kato, Takafumi, Mikami, Yu, Okuda, Kenichi, Gilmore, Rodney C, Conde, Cecilia Domínguez, Gasmi, Billel, Stein, Sydney, Beach, Margaret, Pelayo, Eileen, Maldonado, Jose O, Lafont, Bernard A, Jang, Shyh-Ing, Nasir, Nadia, Padilla, Ricardo J, Murrah, Valerie A, Maile, Robert, Lovell, William, Wallet, Shannon M, Bowman, Natalie M, Meinig, Suzanne L, Wolfgang, Matthew C, Choudhury, Saibyasachi N, Novotny, Mark, Aevermann, Brian D, Scheuermann, Richard H, Cannon, Gabrielle, Anderson, Carlton W, Lee, Rhianna E, Marchesan, Julie T, Bush, Mandy, Freire, Marcelo, Kimple, Adam J, Herr, Daniel L, Rabin, Joseph, Grazioli, Alison, Das, Sanchita, French, Benjamin N, Pranzatelli, Thomas, Chiorini, John A, Kleiner, David E, Pittaluga, Stefania, Hewitt, Stephen M, Burbelo, Peter D, Chertow, Daniel, Frank, Karen, Lee, Janice, Boucher, Richard C, Teichmann, Sarah A, Warner, Blake M, and Byrd, Kevin M

Subjects
Vaccine Related, Dental/Oral and Craniofacial Disease, Pneumonia & Influenza, Infectious Diseases, Emerging Infectious Diseases, Prevention, Digestive Diseases, Biodefense, Pneumonia, Lung, Infection, Good Health and Well Being, Angiotensin-Converting Enzyme 2, Asymptomatic Infections, COVID-19, Humans, Mouth, SARS-CoV-2, Saliva, Serine Endopeptidases, Taste Disorders, Virus Replication, NIH COVID-19 Autopsy Consortium, HCA Oral and Craniofacial Biological Network, Medical and Health Sciences, Immunology
Abstract

Despite signs of infection-including taste loss, dry mouth and mucosal lesions such as ulcerations, enanthema and macules-the involvement of the oral cavity in coronavirus disease 2019 (COVID-19) is poorly understood. To address this, we generated and analyzed two single-cell RNA sequencing datasets of the human minor salivary glands and gingiva (9 samples, 13,824 cells), identifying 50 cell clusters. Using integrated cell normalization and annotation, we classified 34 unique cell subpopulations between glands and gingiva. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry factors such as ACE2 and TMPRSS members were broadly enriched in epithelial cells of the glands and oral mucosae. Using orthogonal RNA and protein expression assessments, we confirmed SARS-CoV-2 infection in the glands and mucosae. Saliva from SARS-CoV-2-infected individuals harbored epithelial cells exhibiting ACE2 and TMPRSS expression and sustained SARS-CoV-2 infection. Acellular and cellular salivary fractions from asymptomatic individuals were found to transmit SARS-CoV-2 ex vivo. Matched nasopharyngeal and saliva samples displayed distinct viral shedding dynamics, and salivary viral burden correlated with COVID-19 symptoms, including taste loss. Upon recovery, this asymptomatic cohort exhibited sustained salivary IgG antibodies against SARS-CoV-2. Collectively, these data show that the oral cavity is an important site for SARS-CoV-2 infection and implicate saliva as a potential route of SARS-CoV-2 transmission.

Published
2021

7. Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes

Author

Smith, Teresa C., Espinoza, Daniel O., Zhu, Yerun, Cardona-Ospina, Jaime A., Bowman, Natalie M., Becker-Dreps, Sylvia, Rouphael, Nadine, Rodriguez-Morales, Alfonso J., Bucardo, Filemon, Edupuganti, Srilatha, Premkumar, Lakshmanane, Mulligan, Mark J., de Silva, Aravinda M., and Collins, Matthew H.

Published
2023
Full Text
View/download PDF

8. Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina

Author

Sciaudone, Michael, Cutshaw, Melissa K., McClean, Colleen M., Lacayo, Roberto, Kharabora, Oksana, Murray, Katherine, Strohminger, Stephen, Zivanovich, Miriana Moreno, Gurnett, Rachel, Markmann, Alena J., Salgado, Emperatriz Morales, Bhowmik, D. Ryan, Castro-Arroyo, Edwin, Boyce, Ross M., Aiello, Allison E., Richardson, David, Juliano, Jonathan J., and Bowman, Natalie M.

Published
2023
Full Text
View/download PDF

9. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.

Author

Joseph, Sarah B, Kincer, Laura P, Bowman, Natalie M, Evans, Chris, Vinikoor, Michael J, Lippincott, Christopher K, Gisslén, Magnus, Spudich, Serena, Menezes, Prema, Robertson, Kevin, Archin, Nancie, Kashuba, Angela, Eron, Joseph J, Price, Richard W, and Swanstrom, Ronald

Subjects
Mental Health, HIV/AIDS, Neurosciences, Infectious Diseases, Aetiology, 2.2 Factors relating to the physical environment, Infection, Adult, Anti-Retroviral Agents, Asymptomatic Diseases, Central Nervous System, Cerebrospinal Fluid, Cohort Studies, Cross-Sectional Studies, Drug Resistance, Viral, Female, HIV Infections, HIV-1, Humans, Longitudinal Studies, Male, Middle Aged, Plasma, RNA, Viral, T-Lymphocytes, Viral Load, CNS, CSF escape, HIV reservoirs, drug resistance, persistence, Biological Sciences, Medical and Health Sciences, Microbiology
Abstract

BACKGROUND:Human immunodeficiency virus type 1 (HIV-1) populations are detected in cerebrospinal fluid (CSF) of some people on suppressive antiretroviral therapy (ART). Detailed analysis of these populations may reveal whether they are produced by central nervous system (CNS) reservoirs. METHODS:We performed a study of 101 asymptomatic participants on stable ART. HIV-1 RNA concentrations were cross-sectionally measured in CSF and plasma. In participants with CSF HIV-1 RNA concentrations sufficient for analysis, viral populations were genetically and phenotypically characterized over multiple time points. RESULTS:For 6% of participants (6 of 101), the concentration of HIV-1 RNA in their CSF was ≥0.5 log copies/mL above that of plasma (ie, CSF escape). We generated viral envelope sequences from CSF of 3 participants. One had a persistent CSF escape population that was macrophage-tropic, partially drug resistant, genetically diverse, and closely related to a minor macrophage-tropic lineage present in the blood prior to viral suppression and enriched for after ART. Two participants (1 suppressed and 1 not) had transient CSF escape populations that were R5 T cell-tropic with little genetic diversity. CONCLUSIONS:Extensive analysis of viral populations in 1 participant revealed that CSF escape was from a persistently replicating population, likely in macrophages/microglia, present in the CNS over 3 years of ART. CSF escape in 2 other participants was likely produced by trafficking and transient expansion of infected T cells in the CNS. Our results show that CNS reservoirs can persist during ART and that CSF escape is not exclusively produced by replicating CNS reservoirs.

Published
2019

10. Role of miR-2392 in driving SARS-CoV-2 infection

Author

Wallet, Shannon M., Maile, Robert, Wolfgang, Matthew C., Hagan, Robert S., Mock, Jason R., Bowman, Natalie M., Torres-Castillo, Jose L., Love, Miriya K., Meinig, Suzanne L., Lovell, Will, Rice, Colleen, Mitchem, Olivia, Burgess, Dominique, Suggs, Jessica, Jacobs, Jordan, McDonald, J. Tyson, Enguita, Francisco J., Taylor, Deanne, Griffin, Robert J., Priebe, Waldemar, Emmett, Mark R., Sajadi, Mohammad M., Harris, Anthony D., Clement, Jean, Dybas, Joseph M., Aykin-Burns, Nukhet, Guarnieri, Joseph W., Singh, Larry N., Grabham, Peter, Baylin, Stephen B., Yousey, Aliza, Pearson, Andrea N., Corry, Peter M., Saravia-Butler, Amanda, Aunins, Thomas R., Sharma, Sadhana, Nagpal, Prashant, Meydan, Cem, Foox, Jonathan, Mozsary, Christopher, Cerqueira, Bianca, Zaksas, Viktorija, Singh, Urminder, Wurtele, Eve Syrkin, Costes, Sylvain V., Davanzo, Gustavo Gastão, Galeano, Diego, Paccanaro, Alberto, Altinok, Selin, Sapoval, Nicolae, Treangen, Todd J., Moraes-Vieira, Pedro M., Vanderburg, Charles, Wallace, Douglas C., Schisler, Jonathan C., Mason, Christopher E., Chatterjee, Anushree, Meller, Robert, and Beheshti, Afshin

Published
2021
Full Text
View/download PDF

12. Small molecule biomarkers predictive of Chagas disease progression

Author

Liu, Zongyuan, primary, Vucetich, Steffany, additional, DeToy, Kelly, additional, Duran Saucedo, Gustavo, additional, Verastegui, Manuela, additional, Carballo-Jimenez, Paula, additional, Mercado-Saavedra, Brandon N., additional, Tinajeros, Freddy, additional, Malaga-Machaca, Edith S., additional, Marcus, Rachel, additional, Gilman, Robert H., additional, Bowman, Natalie M., additional, and McCall, Laura-Isobel, additional

Published
2024
Full Text
View/download PDF

16. 925. Oseltamivir usage in community settings: data from a household transmission study

Author

Mellis, Alexandra, primary, Biddle, Jessica E, additional, Antoon, James W, additional, McLaren, Son H, additional, Belongia, Edward, additional, Maldonado, Yvonne A, additional, Bowman, Natalie M, additional, Ellingson, Katherine, additional, Rao, Suchitra, additional, Johnson, Sheroi, additional, Stockwell, Melissa, additional, Sano, Ellen, additional, Silverio, Raul A, additional, Bullock, Ayla, additional, Yang, Amy, additional, Haehnel, Quenla, additional, McLean, Huong, additional, Petrie, Joshua, additional, Sarnquist, Clea, additional, Govindaranjan, Prasanthi, additional, Goodman, Sara H, additional, Lutrick, Karen, additional, Ledezma, Karla I, additional, Pryor, Kathleen, additional, Asturias, Edwin J, additional, Zhu, Yuwei, additional, Schmitz, Jonathan, additional, Hart, Kimberly W, additional, Grijalva, Carlos G, additional, Talbot, H Keipp, additional, and Rolfes, Melissa A, additional

Published
2023
Full Text
View/download PDF

17. 2293. Examining social vulnerability and its effect on COVID-19 transmission in households

Author

Goodman, Sara H, primary, Mellis, Alexandra, additional, Grijalva, Carlos G, additional, Keipp Talbot, H, additional, Stockwell, Melissa, additional, McLaren, Son H, additional, Sano, Ellen, additional, Rao, Suchitra, additional, Asturias, Edwin J, additional, McLean, Huong, additional, Belongia, Edward, additional, Govindaranjan, Prasanthi, additional, Sarnquist, Clea, additional, Maldonado, Yvonne A, additional, Ellingson, Katherine, additional, Lutrick, Karen, additional, Bowman, Natalie M, additional, Smith-Jeffcoat, Sarah E, additional, Rolfes, Melissa A, additional, Biddle, Jessica E, additional, and Lin, Jessica T, additional

Published
2023
Full Text
View/download PDF

18. 2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection

Author

Rolfes, Melissa A, primary, Talbot, H Keipp, additional, Grace Morrissey, Kerry, additional, Stockwell, Melissa, additional, Maldonado, Yvonne A, additional, McLean, Huong, additional, Lutrick, Karen, additional, Bowman, Natalie M, additional, Rao, Suchitra, additional, Salvatore, Phillip P, additional, Izurieta, Hector, additional, Schmitz, Jonathan, additional, Zhu, Yuwei, additional, Hart, Kimberly W, additional, Battan-Wraith, Steph, additional, Merrill, Lori S, additional, McLaren, Son H, additional, Sano, Ellen, additional, Sarnquist, Clea, additional, Goodman, Sara H, additional, Petrie, Joshua, additional, Ledezma, Karla I, additional, Pryor, Kathleen, additional, Bullock, Ayla, additional, Yang, Amy, additional, Biddle, Jessica E, additional, Smith-Jeffcoat, Sarah E, additional, Johnson, Sheroi, additional, Asturias, Edwin J, additional, Lin, Jessica T, additional, Ellingson, Katherine, additional, Belongia, Edward, additional, Govindaranjan, Prasanthi, additional, Valdez de Romero, Ana, additional, Olivo, Vanessa, additional, Mellis, Alexandra, additional, and Grijalva, Carlos G, additional

Published
2023
Full Text
View/download PDF

19. 400. Predictors of Post-COVID Conditions after SARS-CoV-2 Infection in Adults Enrolled in a Multistate Household Transmission Study

Author

Floris-Moore, Michelle, primary, Stockwell, Melissa, additional, Grijalva, Carlos G, additional, Keipp Talbot, H, additional, Mellis, Alexandra, additional, Smith-Jeffcoat, Sarah E, additional, Rolfes, Melissa A, additional, Saydah, Sharon, additional, Biddle, Jessica E, additional, Lin, Jessica T, additional, Schmitz, Jonathan, additional, Chappell, James, additional, Hart, Kimberly W, additional, McLaren, Son H, additional, Sano, Ellen, additional, Saiman, Lisa, additional, Maldonado, Yvonne A, additional, Ellingson, Katherine, additional, Lutrick, Karen, additional, McLean, Huong, additional, Belongia, Edward, additional, Martin del campo, Zoe, additional, Bullock, Ayla, additional, Rao, Suchitra, additional, Asturias, Edwin J, additional, and Bowman, Natalie M, additional

Published
2023
Full Text
View/download PDF

20. 1327. The Diagnosis of Subarachnoid Neurocysticercosis Is Often Delayed And Other Findings of a Multicenter Retrospective in the USA

Author

Guzmán, Janitzio J, primary, Herrick, Jesica A, additional, Hatlen, Timothy, additional, Weatherhead, Jill E, additional, Clark, Eva, additional, Serpa, Jose, additional, Chow, Felicia, additional, Allyn, Paul R, additional, Wald-Dickler, Noah, additional, Rodriguez, Jorge M, additional, Bowman, Natalie M, additional, Cervantes-Arslanian, Anna, additional, Coyle, Christina, additional, White, A Clinton Clinton, additional, Amusu, Senate, additional, Martin, Dannae, additional, Duffey, Megan M, additional, Larsen, Travis, additional, Welford, Elliott M, additional, Jenks, Jeffrey D, additional, Cowell, Anne, additional, Henao Martínez, Andrés F, additional, Franco-Paredes, Carlos, additional, Mathisen, Glenn, additional, Lichtenberger, Paola, additional, Bouzigard, Rory, additional, Castellino, Laila M, additional, and O’Connell, Elise M, additional

Published
2023
Full Text
View/download PDF

21. 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study

Author

Mellis, Alexandra, primary, Smith-Jeffcoat, Sarah E, additional, Petrie, Joshua, additional, Keipp Talbot, H, additional, Morrissey, Kerry Grace, additional, Stockwell, Melissa, additional, Maldonado, Yvonne A, additional, Bowman, Natalie M, additional, Lutrick, Karen, additional, Rao, Suchitra, additional, Salvatore, Phillip P, additional, Biddle, Jessica E, additional, Olivo, Vanessa, additional, Battan-Wraith, Steph, additional, Merrill, Lori S, additional, McLaren, Son H, additional, Sano, Ellen, additional, Diaz, Anny, additional, Sarnquist, Clea, additional, Govindaranjan, Prasanthi, additional, Goodman, Sara H, additional, Ellingson, Katherine, additional, Ledezma, Karla I, additional, Pryor, Kathleen, additional, Lin, Jessica T, additional, Bullock, Ayla, additional, Yang, Amy, additional, Belongia, Edward, additional, McLean, Huong, additional, Asturias, Edwin J, additional, Izurieta, Hector, additional, Hart, Kimberly W, additional, Schmitz, Jonathan, additional, Zhu, Yuwei, additional, Rolfes, Melissa A, additional, and Grijalva, Carlos G, additional

Published
2023
Full Text
View/download PDF

22. 930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment

Author

Smith-Jeffcoat, Sarah E, primary, Biddle, Jessica E, additional, Talbot, H Keipp, additional, Olivo, Vanessa, additional, Sano, Ellen, additional, Goodman, Sara H, additional, Petrie, Joshua, additional, Ledezma, Karla I, additional, Bullock, Ayla, additional, Rao, Suchitra, additional, Mellis, Alexandra, additional, Johnson, Sheroi, additional, Kirking, Hannah L, additional, Rolfes, Melissa A, additional, Zhu, Yuwei, additional, Schmitz, Jonathan, additional, Hart, Kimberly W, additional, Battan-Wraith, Steph, additional, Merrill, Lori S, additional, McLaren, Son H, additional, Vargas, Celibell, additional, Sarnquist, Clea, additional, Govindaranjan, Prasanthi, additional, Belongia, Edward, additional, Pryor, Kathleen, additional, Lutrick, Karen, additional, Yang, Amy, additional, Haehnel, Quenla, additional, Asturias, Edwin J, additional, Bowman, Natalie M, additional, Ellingson, Katherine, additional, McLean, Huong, additional, Maldonado, Yvonne A, additional, Stockwell, Melissa, additional, Morrissey, Kerry Grace, additional, Grijalva, Carlos G, additional, and Salvatore, Phillip P, additional

Published
2023
Full Text
View/download PDF

23. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals

Author

Smith-Jeffcoat, Sarah E, primary, Biddle, Jessica E, additional, Talbot, H Keipp, additional, Morrissey, Kerry Grace, additional, Stockwell, Melissa S, additional, Maldonado, Yvonne, additional, McLean, Huong Q, additional, Ellingson, Katherine D, additional, Bowman, Natalie M, additional, Asturias, Edwin, additional, Mellis, Alexandra M, additional, Johnson, Sheroi, additional, Kirking, Hannah L, additional, Rolfes, Melissa A R, additional, Olivo, Vanessa, additional, Merrill, Lori, additional, Battan-Wraith, Steph, additional, Sano, Ellen, additional, McLaren, Son H, additional, Vargas, Celibell Y, additional, Goodman, Sara, additional, Sarnquist, Clea C, additional, Govindaranjan, Prasanthi, additional, Petrie, Joshua G, additional, Belongia, Edward A, additional, Ledezma, Karla, additional, Pryor, Kathleen, additional, Lutrick, Karen, additional, Bullock, Ayla, additional, Yang, Amy, additional, Haehnel, Quenla, additional, Rao, Suchitra, additional, Zhu, Yuwei, additional, Schmitz, Jonathan, additional, Hart, Kimberly, additional, Grijalva, Carlos G, additional, and Salvatore, Phillip P, additional

Published
2023
Full Text
View/download PDF

24. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals.

Author

Smith-Jeffcoat, Sarah E, Biddle, Jessica E, Talbot, H Keipp, Morrissey, Kerry Grace, Stockwell, Melissa S, Maldonado, Yvonne, McLean, Huong Q, Ellingson, Katherine D, Bowman, Natalie M, Asturias, Edwin, Mellis, Alexandra M, Johnson, Sheroi, Kirking, Hannah L, Rolfes, Melissa A R, Olivo, Vanessa, Merrill, Lori, Battan-Wraith, Steph, Sano, Ellen, McLaren, Son H, and Vargas, Celibell Y

Subjects
VIRAL load, RESEARCH funding, POLYMERASE chain reaction, TREATMENT effectiveness, QUANTITATIVE research, ANTIVIRAL agents, OUTPATIENTS, RITONAVIR, COVID-19
Abstract

Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus disease 2019 (COVID-19); however, rebound after treatment has been reported. We compared symptom and viral dynamics in individuals with COVID-19 who completed N/R treatment and similar untreated individuals. Methods We identified symptomatic participants who tested severe acute respiratory syndrome coronavirus 2–positive and were N/R eligible from a COVID-19 household transmission study. Index cases from ambulatory settings and their households contacts were enrolled. We collected daily symptoms, medication use, and respiratory specimens for quantitative polymerase chain reaction for 10 days during March 2022—May 2023. Participants who completed N/R treatment (treated) were propensity score matched to untreated participants. We compared symptom rebound, viral load (VL) rebound, average daily symptoms, and average daily VL by treatment status measured after N/R treatment completion or 7 days after symptom onset if untreated. Results Treated (n = 130) and untreated participants (n = 241) had similar baseline characteristics. After treatment completion, treated participants had greater occurrence of symptom rebound (32% vs 20%; P =.009) and VL rebound (27% vs 7%; P <.001). Average daily symptoms were lower among treated participants without symptom rebound (1.0 vs 1.6; P <.01) but not statistically lower with symptom rebound (3.0 vs 3.4; P =.5). Treated participants had lower average daily VLs without VL rebound (0.9 vs 2.6; P <.01) but not statistically lower with VL rebound (4.8 vs 5.1; P =.7). Conclusions Individuals who completed N/R treatment experienced fewer symptoms and lower VL but rebound occured more often compared with untreated individuals. Providers should prescribe N/R, when indicated, and communicate rebound risk to patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients.

Author

Roca, Cristian, Asturizaga, Adriana, Villca, Nelson, Cabrera, Ramiro, Copana-Olmos, Raul, Aguilera-Avendano, Vladimir, Estrada-Villarroel, Claudia, Forest-Yepez, Mariel Andrea, Torrez-Santos, Marcia, Magne-Calle, Adela Felipa, Foronda-Rios, Maria Ofelia, Pena-Helguero, Liz Malena, Montalvo, Monica, Torrez, Delina, Toco, Mirna, Cespedes, Miguel, Davalos, Ingrid, and Bowman, Natalie M.

Subjects
CHILD patients, COVID-19, MEDICAL care, CHILDREN'S hospitals, INTENSIVE care units, PATHOLOGICAL laboratories, CHILD death
Abstract

COVID-19 affects children less seriously than adults; however, severe cases and deaths are documented. This study objective is to determine socio-demographic, clinical and laboratory indicators associated with severe pediatric COVID-19 and mortality at hospital entrance. A multicenter, retrospective, cross-sectional study was performed in 13 tertiary hospitals in Bolivia. Clinical records were collected retrospectively from patients less than 18 years of age and positive for SARS-CoV-2 infection. All variables were measured at hospital entrance; outcomes of interest were ICU admission and death. A score for disease severity was developed using a logistic regression model. 209 patients were included in the analysis. By the end of the study, 43 (20.6%) of children were admitted to the Intensive care unit (ICU), and 17 (8.1%) died. Five indicators were independently predictive of COVID-19 severity: age below 10 years OR: 3.3 (CI95%: 1.1–10.4), days with symptoms to medical care OR: 2.8 (CI95%: 1.2–6.5), breathing difficulty OR: 3.4 (CI95%: 1.4–8.2), vomiting OR: 3.3 (CI95%: 1.4–7.4), cutaneous lesions OR: 5.6 (CI95%: 1.9–16.6). Presence of three or more of these risk factors at hospital entrance predicted severe disease in COVID-19 positive children. Age, presence of underlying illness, male sex, breathing difficulty, and dehydration were predictive of death in COVID-19 children. Our study identifies several predictors of severe pediatric COVID-19 and death. Incorporating these predictors, we developed a tool that clinicians can use to identify children at high risk of severe COVID-19 in limited-resource settings. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Prolonged Shedding of Zika Virus RNA in Vaginal Secretions, Nicaragua

Author

Reyes, Yaoska, Bowman, Natalie M., Becker-Dreps, Sylvia, Centeno, Edwing, Collins, Matthew H., Liou, Guei-Jiun Alice, and Bucardo, Filemon

Subjects
Diseases, Birth defects, Disease transmission, Zika virus, Infection, Guillain-Barre syndrome, Pregnant women, RNA, Medical schools, Sexually transmitted diseases, Infants, Pregnancy, Health, Women
Abstract

Zika virus swept through the Americas beginning in 2014, with >1 million cases reported through December 2017 (Pan American Health Organization, https://www. paho.org/hq/index.php?option=com_docman&task=doc_ view&Itemid=270&gid=43297&lang=en). Zika virus had been considered relatively [...]

Published
2019
Full Text
View/download PDF

28. Nonsecretor Phenotype Is Associated With Less Risk of Rotavirus-Associated Acute Gastroenteritis in a Vaccinated Nicaraguan Birth Cohort

Author

Reyes, Yaoska, St Jean, Denise T., Bowman, Natalie M., Gonzalez, Fredman, Mijatovic-Rustempasic, Slavica, Becker-Dreps, Sylvia, Svensson, Lennart, Nordgren, Johan, Bucardo, Filemon, Vielot, Nadja A., Reyes, Yaoska, St Jean, Denise T., Bowman, Natalie M., Gonzalez, Fredman, Mijatovic-Rustempasic, Slavica, Becker-Dreps, Sylvia, Svensson, Lennart, Nordgren, Johan, Bucardo, Filemon, and Vielot, Nadja A.

Abstract

Background Histo-blood group antigens (HBGAs) have been associated with rotavirus vaccine take; but the effect of these HBGAs on rotavirus incidence and risk remains poorly explored in vaccinated populations. Methods Rotavirus-associated acute gastroenteritis (AGE) was assessed in 444 Nicaraguan children followed from birth until 3 years of age. AGE episodes were tested for rotavirus by reverse-transcription quantitative polymerase chain reaction, and saliva or blood was used to determine HBGA phenotypes. Cox proportional hazards models were used to estimate the relative hazard of rotavirus AGE by HBGA phenotypes. Results Rotavirus was detected in 109 (7%) stool samples from 1689 AGE episodes over 36 months of observation between June 2017 and July 2021. Forty-six samples were successfully genotyped. Of these, 15 (35%) were rotavirus vaccine strain G1P[8], followed by G8P[8] or G8P[nt] (11 [24%]) and equine-like G3P[8] (11 [24%]). The overall incidence of rotavirus-associated AGE was 9.2 per 100 child-years, and was significantly higher in secretor than nonsecretor children (9.8 vs 3.5/100 child-years, P = .002). Conclusions The nonsecretor phenotype was associated with decreased risk of clinical rotavirus vaccine failure in a vaccinated Nicaraguan birth cohort. These results show the importance of secretor status on rotavirus risk, even in vaccinated children. Overall incidence of rotavirus-associated AGE in a vaccinated Nicaraguan birth cohort was 9.2/100 child-years. Nonsecretor children had less risk of symptomatic rotavirus infection. These results are important in the context of monitoring effectiveness of rotavirus vaccine trough birth cohort studies., Funding Agencies|National Institute of Allergy and Infectious Diseases [R01AI127845, K24AI141744]; Fogarty International Center [D43TW010923]; Takeda Vaccines; Swedish Research Council [2014-02827, 2018-02862]; Mucosa Infection and Inflammation Center of Linkoeping University; Swedish Research Council [2018-02862, 2014-02827] Funding Source: Swedish Research Council; Vinnova [2018-02862] Funding Source: Vinnova

Published
2023
Full Text
View/download PDF

29. Nonsecretor Phenotype Is Associated With Less Risk of Rotavirus-Associated Acute Gastroenteritis in a Vaccinated Nicaraguan Birth Cohort

Author

Reyes, Yaoska, primary, St Jean, Denise T, additional, Bowman, Natalie M, additional, González, Fredman, additional, Mijatovic-Rustempasic, Slavica, additional, Becker-Dreps, Sylvia, additional, Svensson, Lennart, additional, Nordgren, Johan, additional, Bucardo, Filemón, additional, and Vielot, Nadja A, additional

Published
2023
Full Text
View/download PDF

30. Visual findings in children exposed to Zika in utero in Nicaragua

Author

Martinez, Evelin, primary, Max, Ryan, additional, Bucardo, Filemón, additional, Stringer, Elizabeth M., additional, Becker-Dreps, Sylvia, additional, Toval-Ruíz, Christian, additional, Chavarria, Meylin, additional, Meléndez-Balmaceda, María J., additional, Nuñez, Carlos, additional, Collins, Matthew H., additional, Boivin, Michael, additional, Ortiz-Pujols, Shiara, additional, Zepeda, Omar, additional, Cross, Kaitlyn, additional, Gower, Emily W., additional, Bowman, Natalie M., additional, and Grace, Sara F., additional

Published
2023
Full Text
View/download PDF

31. Amplicon sequencing reveals complex infection in infants congenitally infected with Trypanosoma cruzi and informs the dynamics of parasite transmission

Author

Hakim, Jill M. C., Waltmann, Andreea, Tinajeros, Freddy, Kharabora, Oksana, Málaga Machaca, Edith Silvia, Calderón Sánchez, Maritza Mercedes, Menduiña, María Del Carmen, Wang, Jeremy, Rueda, Daniel, Zimic-Peralta, Mirko Juan, Verastegui Pimentel, Manuela Renee, Juliano, Jonathan J., Gilman, Robert H., Mugnier, Monica R., and Bowman, Natalie M.

Subjects
Congenital Chagas, Enfermedad de Chagas, Trypanosoma cruzi, Análisis de Secuencia de ADN, Amplicon sequencing
Abstract

Congenital transmission of Trypanosoma cruzi is an important source of new Chagas infections worldwide. The mechanisms of congenital transmission remain poorly understood, but there is evidence that parasite factors are involved. Investigating changes in parasite strain diversity during transmission could provide insight into the parasite factors that influence the process. Here we use amplicon sequencing of a single copy T. cruzi gene to evaluate the diversity of infection in clinical samples from Chagas positive mothers and their infected infants. Several infants and mothers were infected with multiple parasite strains, mostly of the same TcV lineage, and parasite strain diversity was higher in infants than mothers. Two parasite haplotypes were detected exclusively in infant samples, while one haplotype was never found in infants. Together, these data suggest multiple parasites initiate a congenital infection and that parasite factors influence the probability of vertical transmission.

Published
2023

32. Antibody Immunity to Zika Virus among Young Children in a Flavivirus-Endemic Area in Nicaragua

Author

Zepeda, Omar, primary, Espinoza, Daniel O., additional, Martinez, Evelin, additional, Cross, Kaitlyn A., additional, Becker-Dreps, Sylvia, additional, de Silva, Aravinda M., additional, Bowman, Natalie M., additional, Premkumar, Lakshmanane, additional, Stringer, Elizabeth M., additional, Bucardo, Filemón, additional, and Collins, Matthew H., additional

Published
2023
Full Text
View/download PDF

34. Household Transmission of Influenza A Viruses in 2021-2022

Author

Rolfes, Melissa A., primary, Talbot, H. Keipp, additional, McLean, Huong Q., additional, Stockwell, Melissa S., additional, Ellingson, Katherine D., additional, Lutrick, Karen, additional, Bowman, Natalie M., additional, Bendall, Emily E., additional, Bullock, Ayla, additional, Chappell, James D., additional, Deyoe, Jessica E., additional, Gilbert, Julie, additional, Halasa, Natasha B., additional, Hart, Kimberly E., additional, Johnson, Sheroi, additional, Kim, Ahra, additional, Lauring, Adam S., additional, Lin, Jessica T., additional, Lindsell, Christopher J., additional, McLaren, Son H., additional, Meece, Jennifer K., additional, Mellis, Alexandra M., additional, Moreno Zivanovich, Miriana, additional, Ogokeh, Constance E., additional, Rodriguez, Michelle, additional, Sano, Ellen, additional, Silverio Francisco, Raul A., additional, Schmitz, Jonathan E., additional, Vargas, Celibell Y., additional, Yang, Amy, additional, Zhu, Yuwei, additional, Belongia, Edward A., additional, Reed, Carrie, additional, and Grijalva, Carlos G., additional

Published
2023
Full Text
View/download PDF

35. Clinical and Metagenomic Characterization of Neurological Infections of People With Human Immunodeficiency Virus in the Peruvian Amazon.

Author

Steinberg, Hannah E, Ramachandran, Prashanth S, Diestra, Andrea, Pinchi, Lynn, Ferradas, Cusi, Kirwan, Daniela E, Diaz, Monica M, Sciaudone, Michael, Wapniarski, Annie, Zorn, Kelsey C, Calderón, Maritza, Cabrera, Lilia, Pinedo-Cancino, Viviana, Wilson, Michael R, Asayag, Cesar Ramal, Gilman, Robert H, Bowman, Natalie M, and Peru, Toxoplasmosis Working Group in

Subjects
HIV infections, AIDS-related opportunistic infections, TUBERCULOUS meningitis, CENTRAL nervous system infections, OPPORTUNISTIC infections, ANTIGEN analysis, METAGENOMICS
Abstract

Background Neurological opportunistic infections cause significant morbidity and mortality in people with human immunodeficiency virus (HIV) but are difficult to diagnose. Methods One hundred forty people with HIV with acute neurological symptoms from Iquitos, Peru, were evaluated for cerebral toxoplasmosis with quantitative polymerase chain reaction (qPCR) of cerebrospinal fluid (CSF) and for cryptococcal meningitis with cryptococcal antigen test (CrAg) in serum or CSF. Differences between groups were assessed with standard statistical methods. A subset of samples was evaluated by metagenomic next-generation sequencing (mNGS) of CSF to compare standard diagnostics and identify additional diagnoses. Results Twenty-seven participants were diagnosed with cerebral toxoplasmosis by qPCR and 13 with cryptococcal meningitis by CrAg. Compared to participants without cerebral toxoplasmosis, abnormal Glasgow Coma Scale score (P =.05), unilateral focal motor signs (P =.01), positive Babinski reflex (P =.01), and multiple lesions on head computed tomography (CT) (P =.002) were associated with cerebral toxoplasmosis. Photophobia (P =.03) and absence of lesions on head CT (P =.02) were associated with cryptococcal meningitis. mNGS of 42 samples identified 8 cases of cerebral toxoplasmosis, 7 cases of cryptococcal meningitis, 5 possible cases of tuberculous meningitis, and incidental detections of hepatitis B virus (n = 1) and pegivirus (n = 1). mNGS had a positive percentage agreement of 71% and a negative percentage agreement of 91% with qPCR for T gondii. mNGS had a sensitivity of 78% and specificity of 100% for Cryptococcus diagnosis. Conclusions An infection was diagnosed by any method in only 34% of participants, demonstrating the challenges of diagnosing neurological opportunistic infections in this population and highlighting the need for broader, more sensitive diagnostic tests for central nervous system infections. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

37. Timing and genotype distribution of symptomatic and asymptomatic sapovirus infections and re-infections in a Nicaraguan birth cohort

Author

González, Fredman, primary, Diez-Valcarce, Marta, additional, Reyes, Yaoska, additional, Vielot, Nadja A., additional, Toval-Ruíz, Christian, additional, Gutiérrez, Lester, additional, Zepeda, Omar, additional, Cuadra, Edwing Centeno, additional, Blandón, Patricia, additional, Browne, Hannah, additional, Bowman, Natalie M., additional, Vílchez, Samuel, additional, Vinjé, Jan, additional, Becker-Dreps, Sylvia, additional, and Bucardo, Filemón, additional

Published
2022
Full Text
View/download PDF

38. Amplicon Sequencing Reveals Complex Infection in Infants Congenitally Infected With Trypanosoma Cruzi and Informs the Dynamics of Parasite Transmission.

Author

Hakim, Jill M C, Waltmann, Andreea, Tinajeros, Freddy, Kharabora, Oksana, Machaca, Edith Málaga, Calderon, Maritza, Menduiña, María del Carmen, Wang, Jeremy, Rueda, Daniel, Zimic, Mirko, Verástegui, Manuela, Juliano, Jonathan J, Gilman, Robert H, Mugnier, Monica R, Bowman, Natalie M, and Group, Chagas Working

Subjects
TRYPANOSOMA cruzi, INFECTIOUS disease transmission, INFANTS, HAPLOTYPES, CONGENITAL disorders, INFECTION
Abstract

Congenital transmission of Trypanosoma cruzi is an important source of new Chagas infections worldwide. The mechanisms of congenital transmission remain poorly understood, but there is evidence that parasite factors are involved. Investigating changes in parasite strain diversity during transmission could provide insight into the parasite factors that influence the process. Here we use amplicon sequencing of a single copy T. cruzi gene to evaluate the diversity of infection in clinical samples from Chagas positive mothers and their infected infants. Several infants and mothers were infected with multiple parasite strains, mostly of the same TcV lineage, and parasite strain diversity was higher in infants than mothers. Two parasite haplotypes were detected exclusively in infant samples, while one haplotype was never found in infants. Together, these data suggest multiple parasites initiate a congenital infection and that parasite factors influence the probability of vertical transmission. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

39. Neurological and neuropsychological sequelae of Zika virus infection in children in León, Nicaragua

Author

Lebov, Jill F., primary, Hooper, Stephen R., additional, Pugh, Norma, additional, Becker-Dreps, Sylvia, additional, Bowman, Natalie M., additional, Brown, Linda M., additional, MacDonald, Pia D.M., additional, Lakshmanane, Premkumar, additional, Jadi, Ramesh, additional, Bucardo, Filemon, additional, Chevez, Tatiana, additional, Rodriguez, Andrés Herrera, additional, and Aleman Rivera, Teresa de Jesús, additional

Published
2022
Full Text
View/download PDF

40. SARS-CoV-2 seroprevalence and risk factors among meat packing, produce processing, and farm workers

Author

Klein, Melissa D., primary, Sciaudone, Michael, additional, Richardson, David, additional, Lacayo, Roberto, additional, McClean, Colleen M., additional, Kharabora, Oksana, additional, Murray, Katherine, additional, Zivanovich, Miriana Moreno, additional, Strohminger, Stephen, additional, Gurnett, Rachel, additional, Markmann, Alena J., additional, Bhowmik, D. Ryan, additional, Salgado, Emperatriz Morales, additional, Castro-Arroyo, Edwin, additional, Aiello, Allison E., additional, Boyce, Ross M., additional, Juliano, Jonathan J., additional, and Bowman, Natalie M., additional

Published
2022
Full Text
View/download PDF

45. Finding mutations in all the wrong places: Prevalence of knock-down resistance F1534S mutations among Aedes albopictus (family: Culicidae, order: Diptera) in North Carolina

Author

Abernathy, Haley A., primary, Hollingsworth, Brandon D., additional, Giandomenico, Dana A., additional, Moser, Kara A., additional, Juliano, Jonathan J., additional, Bowman, Natalie M., additional, George, Phillip J., additional, Reiskind, Michael H., additional, and Boyce, Ross M., additional

Published
2022
Full Text
View/download PDF

46. Deep Sequencing to Detect Diversity of Trypanosoma cruzi Infection in Patients Coinfected With Human Immunodeficiency Virus and Chagas Disease

Author

Bowman, Natalie M, Balasubramanian, Sujata, Gilman, Robert H, Parobek, Christian, Calderon, Maritza, Waltmann, Andreea, Messenger, Louisa A, Sanchez, Leny, Bern, Caryn, Juliano, Jonathan J, and Working Group on Chagas Disease in Bolivia and Peru

Subjects
fungi, parasitic diseases, food and beverages
Abstract

Chagas disease, caused by Trypanosoma cruzi, can reactivate and cause severe acute disease in immunocompromised patients such as those infected with human immunodeficiency virus (HIV). We conducted amplicon deep sequencing of a 327-bp fragment of the tcscd5 gene using an Ion Torrent PGM directly from clinical samples from HIV patients with high parasitemia. We describe the within-host diversity, both characterizing the discrete typing unit of the infections and confirming the presence of multistrain infections, directly from clinical samples. This method can rapidly provide information on the genetic diversity of T. cruzi infection, which can have direct impacts on clinical disease.

Published
2021

47. IgG Subclasses and Congenital Transmission of Chagas Disease

Author

Roca, Cristian, primary, Málaga-Machaca, Edith S., additional, Verastegui, Manuela R., additional, Scola, Billy, additional, Valencia-Ayala, Edward, additional, Menduiña, Maria del Carmen, additional, Noazin, Sassan, additional, Bowman, Natalie M., additional, Tinajeros, Freddy, additional, Gilman, Robert H., additional, and _, _, additional

Published
2021
Full Text
View/download PDF

48. Clinical and Epidemiological Features of Acute Zika Virus Infections in León, Nicaragua

Author

Bowman, Natalie M., primary, Bucardo, Filemón, additional, Collins, Matthew H., additional, Reyes, Yaoska, additional, Centeno Cuadra, Edwing, additional, Blette, Bryan, additional, Lakshmanane, Premkumar, additional, Guerra, Enrique Paulo, additional, Rubinstein, Rebecca, additional, Liou, Guei-Jiun Alice, additional, de Silva, Aravinda M., additional, and Becker-Dreps, Sylvia, additional

Published
2021
Full Text
View/download PDF

49. Role of miR-2392 in driving SARS-CoV-2 infection

Author

McDonald, J. Tyson, primary, Enguita, Francisco J., additional, Taylor, Deanne, additional, Griffin, Robert J., additional, Priebe, Waldemar, additional, Emmett, Mark R., additional, Sajadi, Mohammad M., additional, Harris, Anthony D., additional, Clement, Jean, additional, Dybas, Joseph M., additional, Aykin-Burns, Nukhet, additional, Guarnieri, Joseph W., additional, Singh, Larry N., additional, Grabham, Peter, additional, Baylin, Stephen B., additional, Yousey, Aliza, additional, Pearson, Andrea N., additional, Corry, Peter M., additional, Saravia-Butler, Amanda, additional, Aunins, Thomas R., additional, Sharma, Sadhana, additional, Nagpal, Prashant, additional, Meydan, Cem, additional, Foox, Jonathan, additional, Mozsary, Christopher, additional, Cerqueira, Bianca, additional, Zaksas, Viktorija, additional, Singh, Urminder, additional, Wurtele, Eve Syrkin, additional, Costes, Sylvain V., additional, Davanzo, Gustavo Gastão, additional, Galeano, Diego, additional, Paccanaro, Alberto, additional, Meinig, Suzanne L., additional, Hagan, Robert S., additional, Bowman, Natalie M., additional, Wolfgang, Matthew C., additional, Altinok, Selin, additional, Sapoval, Nicolae, additional, Treangen, Todd J., additional, Moraes-Vieira, Pedro M., additional, Vanderburg, Charles, additional, Wallace, Douglas C., additional, Schisler, Jonathan C., additional, Mason, Christopher E., additional, Chatterjee, Anushree, additional, Meller, Robert, additional, Beheshti, Afshin, additional, Wallet, Shannon M., additional, Maile, Robert, additional, Mock, Jason R., additional, Torres-Castillo, Jose L., additional, Love, Miriya K., additional, Lovell, Will, additional, Rice, Colleen, additional, Mitchem, Olivia, additional, Burgess, Dominique, additional, Suggs, Jessica, additional, and Jacobs, Jordan, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results